Search Results for "Inositol 1,4,5-trisphosphate" - 49 interactions found in 19 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
439
1925 Phosphatidylinositol-4,5-bisphosphate affects_activity of Inositol 1,4,5-trisphosphate in pilocarpine model
1471196 Status epilepticus
440
1940 Inositol 1,4,5-trisphosphate interacts (colocalizes) with ITPR1 in pilocarpine model
1648604 Neurological
Status epilepticus
4,660
46388 PLC increases_quantity of Inositol 1,4,5-trisphosphate in pancreas, in pancreatic islets
46390 Inositol 1,4,5-trisphosphate increases_activity of calcium-mediated signaling in pancreas, in pancreatic islets
46447 Inositol 1,4,5-trisphosphate increases_activity of ITPR in pancreas, in pancreatic islets; via binding to the receptor
21966580 Diabetes mellitus, type II
Schizophrenia
Insulin resistance
4,686
46621 PLCB increases_quantity of Inositol 1,4,5-trisphosphate in pancreas, in pancreatic islet beta cells
46623 Inositol 1,4,5-trisphosphate increases_activity of ITPR in pancreas, in pancreatic islet beta cells; via binding of IP3 to its receptor
24114586 Bipolar disorder
Diabetes mellitus, type II
Schizophrenia
Insulin resistance
5,058
49756 PLCB2 increases_quantity of Inositol 1,4,5-trisphosphate
8245028 Neurological
5,059
49755 Inositol 1,4,5-trisphosphate interacts (colocalizes) with IP3R receptor complex
49774 Inositol 1,4,5-trisphosphate is_part_of IP3-IP3R receptor complex
16919684 Neurological
5,441
53112 LRP5 affects_quantity of Inositol 1,4,5-trisphosphate
12509515 Diabetes mellitus, type II
Insulin resistance
6,492
61981 PLC increases_quantity of Inositol 1,4,5-trisphosphate
62203 Phosphatidylinositol-4,5-bisphosphate increases_quantity of Inositol 1,4,5-trisphosphate
62346 Inositol 1,4,5-trisphosphate increases_activity of calcium-mediated signaling
15471909 Metabolic
6,517
61973 Lithium decreases_quantity of Inositol 1,4,5-trisphosphate
62095 Inositol increases_quantity of Inositol 1,4,5-trisphosphate
62105 Inositol 1,4,5-trisphosphate decreases_activity of autophagy
16186256 Metabolic
7,296
71673 SYNJ1 decreases_quantity of Inositol 1,4,5-trisphosphate
15474001 Diabetes mellitus, type II
Insulin resistance
Ciliopathy
7,420
72888 PLC increases_quantity of Inositol 1,4,5-trisphosphate
72891 Inositol 1,4,5-trisphosphate affects_activity of insulin secretion involved in cellular response to glucose stimulus
72892 Inositol 1,4,5-trisphosphate increases_quantity of Inositol 3,4,5,6-tetrakisphosphate
72893 Inositol 1,4,5-trisphosphate increases_quantity of Inositol 1,2,3,4,5,6-hexakisphosphate
72895 Inositol 1,4,5-trisphosphate increases_quantity of 5-PP-InsP5
72896 Inositol 1,4,5-trisphosphate increases_quantity of Bisdiphosphoinositol tetrakisphosphate
26862218 Diabetes mellitus, type II
Insulin resistance
9,120
96845 PLC increases_quantity of Inositol 1,4,5-trisphosphate
25960051 Arterial calcification, generalized, of infancy, 1
11,358
114099 Inositol 1,4,5-trisphosphate increases_activity of Calcium-release channel when activated by IP3, releasing Ca+ from ER lumen into cytoplasm
114106 Fas signaling pathway increases_quantity of Inositol 1,4,5-trisphosphate via the activation of phospholipase C-gamma1, and the subsequent enhanced Ca2+ release from IP3 receptors
114107 Inositol 1,4,5-trisphosphate interacts (colocalizes) with ITPR serving as second messenger
114108 Inositol 1,4,5-trisphosphate is_part_of ITPR-IP3 complex localized in ER membrane; Fas-signaling-induced apoptosis involves the increase of IP3 production, via the activation of PLCG1
114109 Inositol 1,4,5-trisphosphate increases_activity of calcium ion import into cytosol from ER lumen into cytosol; the activation of PLCG1 enhanced Ca2+ release from IP3 receptors, creating an increased intracellar free calcium level; IP3 acts as second messenger
114110 PLCG1 increases_quantity of Inositol 1,4,5-trisphosphate in cytosol; PLCG cleaves PIP2 into DAG and IP3
114111 Inositol 1,4,5-trisphosphate increases_activity of ITPR localized in ER membrane; resulting in an enhanced Ca2+ release from IP3 receptors
114129 Inositol 1,4,5-trisphosphate increases_activity of tricarboxylic acid cycle in mitochondria; by increasing mitochondrial matrix Ca2+ concentration
19144519 Metabolic
11,492
114705 Inositol 1,4,5-trisphosphate increases_activity of ITPr generated by phospholipase C (PLC) in response to the activation of various G-protein-coupled receptors (GPCRs) or of tyrosine kinase-linked receptors
114791 Inositol 1,4,5-trisphosphate increases_activity of second-messenger-mediated signaling Ca2+-release through IP3Rs requires binding of the second messenger IP3
114812 PLC increases_quantity of Inositol 1,4,5-trisphosphate
18478527 Alzheimer disease
11,493
114722 ATP increases_activity of Inositol 1,4,5-trisphosphate ATP alone was not sufficient to open the IP3-gated channel, but addition of ATP or non-hydrolyzable ATP analogs in the presence of IP3 increased the frequency and average duration of channel openings
7686381 Metabolic
11,523
114998 Phosphatidylinositol-4,5-bisphosphate increases_quantity of Inositol 1,4,5-trisphosphate PIP2 is the precursor of inositol triphosphate (IP3) resulting from cleavage by phospholipase C (PLC)
114999 Inositol 1,4,5-trisphosphate increases_activity of calcium ion export from endoplasmic reticulum
115002 PLC increases_quantity of Inositol 1,4,5-trisphosphate when PLC is activated
115060 Inositol 1,4,5-trisphosphate interacts (colocalizes) with ITPR
115061 Inositol 1,4,5-trisphosphate increases_activity of Calcium-release channel increased concentration of IP3 triggers the release of Ca2+ from intracellular stores after binding to IP3 receptors
23798435 Metabolic
11,762
116467 Inositol 1,4,5-trisphosphate increases_activity of calcium ion import into cytosol releasing Ca2+ from the intracellular stores through IP3 receptor channels
19422456 Metabolic
14,301
134933 PLCG2-PRKCA complex increases_quantity of Inositol 1,4,5-trisphosphate
16923831 Metabolic
15,346
145088 Verapamil decreases_quantity of Inositol 1,4,5-trisphosphate inducing the degradation of aggregate-prone proteins
145089 Loperamide decreases_quantity of Inositol 1,4,5-trisphosphate inducing the degradation of aggregate-prone proteins
145090 Clonidine decreases_quantity of Inositol 1,4,5-trisphosphate inducing the degradation of aggregate-prone proteins
145091 CAST decreases_quantity of Inositol 1,4,5-trisphosphate inducing the degradation of aggregate-prone proteins
145092 Inositol 1,4,5-trisphosphate decreases_activity of autophagosome assembly inducing the degradation of aggregate-prone proteins
Alzheimer disease
-->